{"id":7771,"date":"2021-01-06T06:42:32","date_gmt":"2021-01-06T06:42:32","guid":{"rendered":"https:\/\/www.nicox.com\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\/"},"modified":"2021-01-06T06:42:32","modified_gmt":"2021-01-06T06:42:32","slug":"nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2","status":"publish","type":"post","link":"https:\/\/www.nicox.com\/fr\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\/","title":{"rendered":"Nicox : Lancement de VYZULTA au Mexique par son partenaire Bausch + Lomb"},"content":{"rendered":"<p>Sophia Antipolis, France<\/p>\n<p><strong>\u00a0<\/strong><strong>Nicox SA<\/strong> (Euronext Paris : FR0013018124, COX, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce le lancement de VYZULTA<sup>\u00ae<\/sup> (solution ophtalmique de latanoprost\u00e8ne bunod), 0,024% au Mexique par une filiale de son partenaire Bausch + Lomb. L\u2019approbation r\u00e9glementaire de mise sur le march\u00e9 de VYZULTA au Mexique a \u00e9t\u00e9 obtenue en janvier 2020.<\/p>\n<p>Approuv\u00e9 pour la premi\u00e8re fois par la <em>Food and Drug Administration<\/em> am\u00e9ricaine fin 2017, VYZULTA est commercialis\u00e9 aux \u00c9tats-Unis, au Canada, en Argentine et au Mexique et est approuv\u00e9 pour commercialisation dans quatre autres territoires &#8211; Colombie, Hong Kong, Taiwan et Ukraine. VYZULTA est indiqu\u00e9 pour la r\u00e9duction de la pression intraoculaire chez les patients atteints de glaucome \u00e0 angle ouvert ou d&rsquo;hypertension oculaire. Bausch Health Companies Inc. (NYSE\/TSX: BHC) et sa filiale Bausch + Lomb, leader mondial en sant\u00e9 oculaire, poursuivent la soumission de demandes d\u2019approbation dans des territoires o\u00f9 les donn\u00e9es cliniques de l\u2019enregistrement am\u00e9ricain peuvent \u00eatre utilis\u00e9es pour approbation par les autorit\u00e9s r\u00e9glementaires locales.<\/p>\n<p>Selon les termes de l\u2019accord de concession de licence exclusif avec Bausch + Lomb, Nicox re\u00e7oit des redevances croissantes de 6% \u00e0 12% sur les ventes nettes mondiales de VYZULTA et des paiements d\u2019\u00e9tape potentiels pouvant atteindre un montant de 150 millions de dollars.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sophia Antipolis, France \u00a0Nicox SA (Euronext Paris : FR0013018124, COX, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce le lancement de VYZULTA\u00ae (solution ophtalmique de latanoprost\u00e8ne bunod), 0,024% au Mexique par une filiale de son partenaire Bausch + Lomb. L\u2019approbation r\u00e9glementaire de mise sur le march\u00e9 de VYZULTA au Mexique a \u00e9t\u00e9 obtenue en janvier [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[32,16],"tags":[],"class_list":["post-7771","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-media"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nicox : Lancement de VYZULTA au Mexique par son partenaire Bausch + Lomb - Nicox<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nicox.com\/fr\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nicox : Lancement de VYZULTA au Mexique par son partenaire Bausch + Lomb - Nicox\" \/>\n<meta property=\"og:description\" content=\"Sophia Antipolis, France \u00a0Nicox SA (Euronext Paris : FR0013018124, COX, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce le lancement de VYZULTA\u00ae (solution ophtalmique de latanoprost\u00e8ne bunod), 0,024% au Mexique par une filiale de son partenaire Bausch + Lomb. L\u2019approbation r\u00e9glementaire de mise sur le march\u00e9 de VYZULTA au Mexique a \u00e9t\u00e9 obtenue en janvier [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nicox.com\/fr\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Nicox\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-06T06:42:32+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Nicox : Lancement de VYZULTA au Mexique par son partenaire Bausch + Lomb\",\"datePublished\":\"2021-01-06T06:42:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\\\/\"},\"wordCount\":227,\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s et M\u00e9dia\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\\\/\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\\\/\",\"name\":\"Nicox : Lancement de VYZULTA au Mexique par son partenaire Bausch + Lomb - Nicox\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\"},\"datePublished\":\"2021-01-06T06:42:32+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"name\":\"Nicox\",\"description\":\"Visible Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\",\"name\":\"Nicox\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Nicox\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nicox : Lancement de VYZULTA au Mexique par son partenaire Bausch + Lomb - Nicox","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nicox.com\/fr\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Nicox : Lancement de VYZULTA au Mexique par son partenaire Bausch + Lomb - Nicox","og_description":"Sophia Antipolis, France \u00a0Nicox SA (Euronext Paris : FR0013018124, COX, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce le lancement de VYZULTA\u00ae (solution ophtalmique de latanoprost\u00e8ne bunod), 0,024% au Mexique par une filiale de son partenaire Bausch + Lomb. L\u2019approbation r\u00e9glementaire de mise sur le march\u00e9 de VYZULTA au Mexique a \u00e9t\u00e9 obtenue en janvier [&hellip;]","og_url":"https:\/\/www.nicox.com\/fr\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\/","og_site_name":"Nicox","article_published_time":"2021-01-06T06:42:32+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.nicox.com\/fr\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\/#article","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\/"},"author":{"name":"","@id":""},"headline":"Nicox : Lancement de VYZULTA au Mexique par son partenaire Bausch + Lomb","datePublished":"2021-01-06T06:42:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\/"},"wordCount":227,"publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"articleSection":["Actualit\u00e9s","Actualit\u00e9s et M\u00e9dia"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.nicox.com\/fr\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\/","url":"https:\/\/www.nicox.com\/fr\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\/","name":"Nicox : Lancement de VYZULTA au Mexique par son partenaire Bausch + Lomb - Nicox","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/#website"},"datePublished":"2021-01-06T06:42:32+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nicox.com\/fr\/nicox-lancement-de-vyzulta-au-mexique-par-son-partenaire-bausch-lomb-2\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.nicox.com\/fr\/#website","url":"https:\/\/www.nicox.com\/fr\/","name":"Nicox","description":"Visible Science","publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nicox.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.nicox.com\/fr\/#organization","name":"Nicox","url":"https:\/\/www.nicox.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Nicox"},"image":{"@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":""}]}},"_links":{"self":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/comments?post=7771"}],"version-history":[{"count":0,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7771\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/media?parent=7771"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/categories?post=7771"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/tags?post=7771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}